MedPath

European Organisation For Research & Treatment Of Cancer

🇬🇧United Kingdom
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.eortc.be

Study to Assess Cancer Patients' Satisfaction With Hospital Quality of Care

Completed
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
Other: quality-of-life assessment
First Posted Date
2003-01-27
Last Posted Date
2012-08-27
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
795
Registration Number
NCT00045019
Locations
🇸🇪

Sahlgrenska University Hospital, Gothenburg, Sweden

🇫🇷

Institut Curie - Section Medicale, Paris, France

🇫🇷

Centre Paul Strauss, Strasbourg, France

and more 8 locations

Assessing Quality of Life of Patients With Prostate Cancer

Completed
Conditions
Prostate Cancer
Interventions
Other: QoL assessment
First Posted Date
2003-01-27
Last Posted Date
2012-08-27
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
625
Registration Number
NCT00041301
Locations
🇳🇱

Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands

🇳🇱

Academisch Medisch Centrum, Amsterdam, Netherlands

🇳🇱

Rijnstate Hospital, Arnhem, Netherlands

and more 30 locations

Assessing Quality of Life of Patients With Stomach Cancer

Completed
Conditions
Gastric Cancer
Interventions
Other: quality-of-life assessment
First Posted Date
2003-01-27
Last Posted Date
2012-08-27
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
267
Registration Number
NCT00020826
Locations
🇸🇪

Sahlgrenska University Hospital, Gothenburg (Goteborg), Sweden

🇫🇷

Centre Alexis Vautrin, Vandoeuvre-les-Nancy, France

🇩🇪

University of Marburg, Marburg, Germany

and more 4 locations

Combination Chemotherapy in Treating Men With Germ Cell Cancer

Phase 2
Conditions
Extragonadal Germ Cell Tumor
Teratoma
Testicular Germ Cell Tumor
First Posted Date
2003-01-27
Last Posted Date
2012-03-06
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
498
Registration Number
NCT00003643
Locations
🇩🇪

Klinikum der Stadt Mannheim, Mannheim, Germany

🇧🇪

Universitair Ziekenhuis Antwerpen, Edegem, Belgium

🇩🇰

Aarhus Universitetshospital - Aarhus Sygehus, Aarhus, Denmark

and more 66 locations

Vaccine Therapy in Treating Patients With Primary Stage II Melanoma

Phase 3
Conditions
Melanoma (Skin)
First Posted Date
2003-01-27
Last Posted Date
2009-02-09
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Registration Number
NCT00005052
Locations
🇳🇴

Norwegian Radium Hospital, Oslo, Norway

🇮🇹

Universita Degli Studi di Turin, Torino, Italy

🇪🇸

Hospital Universitario 12 de Octubre, Madrid, Spain

and more 76 locations

Lymph Node Radiation Therapy in Patients With Stage I, Stage II, or Stage III Breast Cancer That Has Been Surgically Removed

Phase 3
Conditions
Breast Cancer
First Posted Date
2003-01-27
Last Posted Date
2010-01-29
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
4000
Registration Number
NCT00002851
Locations
🇳🇱

Medisch Spectrum Twente, Enschede, Netherlands

🇳🇱

Radiotherapeutisch Instituut Limburg-Maastricht, Maastricht, Netherlands

🇫🇷

Centre de Lutte Contre le Cancer Georges-Francois Leclerc, Dijon, France

and more 45 locations

Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia

Phase 3
Conditions
Leukemia
First Posted Date
2003-01-27
Last Posted Date
2009-12-23
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
2000
Registration Number
NCT00004128

Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium

Phase 3
Completed
Conditions
Stage III Bladder Cancer
Stage IV Bladder Cancer
Transitional Cell Carcinoma of the Bladder
Interventions
First Posted Date
2003-01-27
Last Posted Date
2016-08-02
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
285
Registration Number
NCT00028756

Surgery and BCG in Treating Patients With Bladder Cancer

Phase 3
Completed
Conditions
Bladder Cancer
First Posted Date
2003-01-27
Last Posted Date
2013-06-12
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
1288
Registration Number
NCT00002990
Locations
🇧🇪

Onze Lieve Vrouw Ziekenhuis Aalst, Aalst, Belgium

🇧🇪

Cliniques Universitaires Saint-Luc, Brussels, Belgium

🇧🇪

Academisch Ziekenhuis der Vrije Universiteit Brussel, Brussels, Belgium

and more 37 locations

Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia

First Posted Date
2003-01-27
Last Posted Date
2012-08-27
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
472
Registration Number
NCT00052299
Locations
🇮🇹

Ospedale San Bortolo, Vicenza, Italy

🇳🇱

Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands

🇦🇹

A. oe. Krankenhaus der Barmherzigen Schwestern Kinderabteilung, Linz, Austria

and more 52 locations
© Copyright 2025. All Rights Reserved by MedPath